NO168177C - Analogifremgangsmaate for fremstilling av terapeutisk aktive polysykliske forbindelser - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive polysykliske forbindelserInfo
- Publication number
- NO168177C NO168177C NO870564A NO870564A NO168177C NO 168177 C NO168177 C NO 168177C NO 870564 A NO870564 A NO 870564A NO 870564 A NO870564 A NO 870564A NO 168177 C NO168177 C NO 168177C
- Authority
- NO
- Norway
- Prior art keywords
- policyclic
- relations
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74486585A | 1985-06-13 | 1985-06-13 | |
US86178886A | 1986-05-15 | 1986-05-15 | |
PCT/US1986/001269 WO1986007359A2 (en) | 1985-06-13 | 1986-06-13 | Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives |
Publications (4)
Publication Number | Publication Date |
---|---|
NO870564L NO870564L (no) | 1987-02-12 |
NO870564D0 NO870564D0 (no) | 1987-02-12 |
NO168177B NO168177B (no) | 1991-10-14 |
NO168177C true NO168177C (no) | 1992-01-22 |
Family
ID=27114362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO870564A NO168177C (no) | 1985-06-13 | 1987-02-12 | Analogifremgangsmaate for fremstilling av terapeutisk aktive polysykliske forbindelser |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0229823B1 (no) |
JP (1) | JPH0762017B2 (no) |
KR (1) | KR900004831B1 (no) |
AT (1) | ATE67764T1 (no) |
AU (1) | AU591922B2 (no) |
CA (1) | CA1306255C (no) |
DE (1) | DE3681719D1 (no) |
DK (1) | DK70687A (no) |
GR (1) | GR861530B (no) |
HK (1) | HK94694A (no) |
HU (1) | HU203098B (no) |
IE (1) | IE60420B1 (no) |
IL (1) | IL79110A0 (no) |
MY (1) | MY101808A (no) |
NO (1) | NO168177C (no) |
NZ (1) | NZ216519A (no) |
OA (1) | OA08480A (no) |
PT (1) | PT82752B (no) |
WO (1) | WO1986007359A2 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3609795A1 (de) * | 1986-03-22 | 1987-09-24 | Goedecke Ag | Pyrido(4,3-b)(1,6)naphthyridin-derivate, verfahren zu deren herstellung und deren verwendung |
US5366971A (en) * | 1987-11-09 | 1994-11-22 | Sandoz Ltd. | Use of 11,28-dioxa-4-azatricyclo[22.3.1.04,9 ]octacos-18-ene derivatives and pharmaceutical compositions containing them |
WO1995028055A1 (en) * | 1994-04-08 | 1995-10-19 | Prevue International, Inc. | Interactive scroll program guide |
SK281341B6 (sk) * | 1994-06-14 | 2001-02-12 | Dainippon Pharmaceutical Co., Ltd. | Deriváty pyridónkarboxylovej kyseliny alebo jej farmaceuticky prijateľných solí, spôsob ich prípravy a farmakologické prostriedky ich obsahujúce |
ES2228370T3 (es) * | 1999-08-30 | 2005-04-16 | Maruishi Pharmaceutical Co., Ltd. | Compuestos de 1,4-dihidro-4-oxoquinolina 1,2-disustituidos. |
US9625475B2 (en) | 2008-09-29 | 2017-04-18 | Abbvie Inc. | Indole and indoline derivatives and methods of use thereof |
HU231285B1 (hu) | 2018-04-18 | 2022-08-28 | Printnet Kereskedelmi És Szolgáltató Kft. | A miozin-2-izoformákat szelektíven gátló, gyógyászatilag hatásos vegyületek |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH498841A (fr) * | 1967-07-13 | 1970-11-15 | Inst Farmaceutyczny | Procédé de préparation de benzo-(b,1,8)-naphtyridones-5 substituées |
DE2803541A1 (de) * | 1978-01-27 | 1979-08-02 | Sandoz Ag | Neue chinolinderivate, ihre herstellung und verwendung |
US4680298A (en) * | 1983-05-31 | 1987-07-14 | Schering Corporation | Tricyclic anti-allergy and use as anti-inflammatory agents |
-
1986
- 1986-06-12 PT PT82752A patent/PT82752B/pt not_active IP Right Cessation
- 1986-06-12 GR GR861530A patent/GR861530B/el unknown
- 1986-06-12 IE IE156586A patent/IE60420B1/en not_active IP Right Cessation
- 1986-06-12 NZ NZ216519A patent/NZ216519A/xx unknown
- 1986-06-12 IL IL79110A patent/IL79110A0/xx not_active IP Right Cessation
- 1986-06-13 DE DE8686904508T patent/DE3681719D1/de not_active Expired - Fee Related
- 1986-06-13 KR KR1019870700130A patent/KR900004831B1/ko not_active IP Right Cessation
- 1986-06-13 AU AU61224/86A patent/AU591922B2/en not_active Ceased
- 1986-06-13 WO PCT/US1986/001269 patent/WO1986007359A2/en active IP Right Grant
- 1986-06-13 JP JP61503579A patent/JPH0762017B2/ja not_active Expired - Lifetime
- 1986-06-13 EP EP86904508A patent/EP0229823B1/en not_active Expired - Lifetime
- 1986-06-13 HU HU863255A patent/HU203098B/hu not_active IP Right Cessation
- 1986-06-13 AT AT86904508T patent/ATE67764T1/de not_active IP Right Cessation
- 1986-06-13 CA CA000511542A patent/CA1306255C/en not_active Expired - Fee Related
-
1987
- 1987-02-06 OA OA59067A patent/OA08480A/xx unknown
- 1987-02-12 NO NO870564A patent/NO168177C/no unknown
- 1987-02-12 DK DK070687A patent/DK70687A/da not_active Application Discontinuation
- 1987-08-10 MY MYPI87001251A patent/MY101808A/en unknown
-
1994
- 1994-09-08 HK HK94694A patent/HK94694A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0229823A1 (en) | 1987-07-29 |
JPS63500518A (ja) | 1988-02-25 |
AU591922B2 (en) | 1989-12-21 |
MY101808A (en) | 1992-01-31 |
HUT42482A (en) | 1987-07-28 |
IE60420B1 (en) | 1994-07-13 |
WO1986007359A3 (en) | 1987-04-09 |
EP0229823B1 (en) | 1991-09-25 |
KR870700622A (ko) | 1987-12-30 |
KR900004831B1 (ko) | 1990-07-07 |
PT82752B (pt) | 1988-12-15 |
AU6122486A (en) | 1987-01-07 |
DK70687D0 (da) | 1987-02-12 |
PT82752A (en) | 1986-07-01 |
NO870564L (no) | 1987-02-12 |
HU203098B (en) | 1991-05-28 |
NO168177B (no) | 1991-10-14 |
NO870564D0 (no) | 1987-02-12 |
IE861565L (en) | 1986-12-13 |
CA1306255C (en) | 1992-08-11 |
GR861530B (en) | 1986-12-31 |
DK70687A (da) | 1987-02-12 |
IL79110A0 (en) | 1986-09-30 |
DE3681719D1 (de) | 1991-10-31 |
WO1986007359A2 (en) | 1986-12-18 |
NZ216519A (en) | 1989-02-24 |
HK94694A (en) | 1994-09-16 |
OA08480A (en) | 1988-07-29 |
JPH0762017B2 (ja) | 1995-07-05 |
ATE67764T1 (de) | 1991-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO168770C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO874869D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
NO168174C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser | |
NO170629C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater | |
NO870397D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser. | |
NO168299C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater | |
NO168177C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive polysykliske forbindelser | |
NO169069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater | |
NO168103C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater | |
NO165923C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylsubstituerte nafthyridinderivater. | |
DK320081A (da) | Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater | |
MY100071A (en) | Aryl-substituted naphthyridine and pyridopyrazine derivatives | |
UA8421A1 (uk) | Препарат для лікування опіків, трофічних язв та раневих пошкоджень шкіри віватон-2 | |
NO170850C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-oxoprostaglandinderivater | |
NO921475D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive catecholderivater |